UK Pharmacist Society Tries to Move Pharmacogenomics Into Mainstream | GenomeWeb

A handful of staffers at the Royal Pharmaceutical Society of Great Britain are devising a plan to build a three-way pharmacogenetics bridge between drug and diagnostic makers, pharmacists, and physicians.

The mission of the association’s working party on pharmacogenetics, now almost two months old, may become a boon for pharmacogenomics tool providers, molecular diagnostics shops, and biopharmas by showing British prescribers that the discipline is very much alive.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.